Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine versus atenolol for chronic stable angina
ACTRN12613000354785Phase 2Completed
- Sponsor
- Fuwai Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ivabradine and atenolol in angina pectoris and coronary arteriosclerosis (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Relative change in total exercise duration during exercise tolerance tests. Started Oct 2009; status: completed.
02
Drugs
ivabradineatenolol
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12613000354785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000354785.